StonvexLoading…
StonvexStonvexStonvexCore line items from CETX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $76.49M | $66.86M | $59.37M | $45.03M |
Operating Income | $509.83K | $-5.27M | $-1.51M | $-14.13M |
Net Income | $-28.11M | $-7.23M | $-9.20M | $-13.02M |
EPS (Diluted) | $-210.88 | $-269.47 | $-15760.64 | $-14.83 |
Total Assets | $47.79M | $44.12M | $48.45M | $45.76M |
Total Liabilities | $39.07M | $39.15M | $40.11M | $31.12M |
Cash & Equivalents | $4.97M | $3.90M | $5.33M | $9.90M |
Free Cash Flow OCF − CapEx | $-1.77M | $-5.25M | $-4.99M | $-17.87M |
Shares Outstanding | 830.61K | 946 | 498 | 754.71K |